Dave
Controversial type 2 diabetes drug Avandia (rosiglitazone) will be withdrawn from the New Zealand market on April 29, 2011, because a New Zealand safety review discovered an increased risk of potentially-fatal heart complications in diabetic patients taking the medication. I wonder what is happening in the USA with this drug?